You are here: Industry Insights > Bharat Biotech

News List

Bharat Biotech gets DCGI nod for PHASE II trials of COVAXIN expresspharma
September 07, 2020
The subject expert committee (SEC) has recommended that the trial will be conducted on 380 participants.
Bharat Biotech gets green signal from CDSCO to test COVAXIN via skin expresspharma
August 24, 2020
As per reports, Bharat Biotech has got an approval from the Drug Controller General of India (DCGI) to conduct a separate clinical trial through which it will test administering their Covid-19 vaccine ‘Covaxin’ through the skin.
Bharat Biotech commences human trial of COVAXIN at PGI Rohtak expresspharma
July 20, 2020
The human trial of Bharat Biotech’s COVID-19 vaccine Covaxin began at Rohtak’s Post-Graduate Institute of Medical Sciences, informed Anil Vij, Health Minister of Haryana through a tweet.
Bharat Biotech starts human trials for Covaxin, India’s first COVID-19 vaccine expresspharma
July 15, 2020
The company had earlier received approval from the Drug Controller General of India (DCGI) to conduct phase I and II human clinical trials.
ICMR-Bharat Biotech to expedite clinical trials of COVID-19 vaccine, plan launch by August 15 expresspharma
July 03, 2020
Presently, 12 clinical trial sites have been identified and ICMR has asked the institutions to enable subject enrolment by the first week of July.
First COVID-19 vaccine clinical trial approved in India europeanpharmaceuticalreview
July 01, 2020
Indian authorities have given the green light to test Bharat Biotech’s COVID-19 vaccine in Phase I and Phase II clinical trials.
COVAXIN from Bharat Biotech gets DCGI approval for Phase I & II Human Clinical Trials expresspharma
June 30, 2020
The human trials of this vaccine candidate for COVID-19, indigenously developed in collaboration with ICMR-NIV, will start across India in July 2020.
Bharat Biotech, Thomas Jefferson University collaborate on COVID-19 vaccine candidate expresspharma
May 21, 2020
The vector used in this new COVID-19 vaccine under accelerated development program is a deactivated rabies vaccine that is known to produce a strong immune response, and is approved for the whole population including children and pregnant women.
ICMR teams up with Bharat Biotech to develop COVID-19 vaccine expresspharma
May 12, 2020
The vaccine will be developed using the virus strain isolated at the ICMR’s National Institute of Virology (NIV), Pune, a statement said.
FluGen, Bharat Biotech and UW–Madison partner on Covid-19 vaccine pharmaceutical-technology
April 06, 2020
Vaccine development companies FluGen and Bharat Biotech have partnered with the University of Wisconsin–Madison (UWMadison) to develop and evaluate a Covid-19 vaccine candidate, CoroFlu.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page